(Q41138049)

27 September 2017

1 reference

title

Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype (English)

1 reference

27 September 2017

A Llerena

1

1 reference

27 September 2017

A Llerena

2

1 reference

27 September 2017

J Cobaleda

3

1 reference

27 September 2017

C Martínez

4

1 reference

27 September 2017

J Benítez

5

1 reference

27 September 2017

publication date

1 April 1996

1 reference

European Journal of Drug Metabolism and Pharmacokinetics

27 September 2017

published in

1 reference

27 September 2017

volume

21

1 reference

27 September 2017

issue

2

1 reference

27 September 2017

page(s)

129-138

1 reference

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03190261

Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distributions analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03190261

A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03190261

Chromosomal assignment of human cytochrome P-450 (debrisoquine/sparteine type) to chromosome 22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03190261

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03190261

The influence of enzyme induction on polymorphic sparteine oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03190261

Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03190261

The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03190261

Changes in rate and pattern of caffeine metabolism after cigarette abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03190261

Influence of the menstrual cycle on the absorption and elimination of D-xylose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03190261

Relationship between personality and debrisoquine hydroxylation capacity

21 January 2018

1 reference

12 December 2020

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

1 reference

12 December 2020

The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes

1 reference

12 December 2020

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

1 reference

12 December 2020

Poor metabolisers of nicotine and CYP2D6 polymorphism

1 reference

12 December 2020

Pregnancy-induced increase in metoprolol metabolism

1 reference

12 December 2020

The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.

1 reference

12 December 2020

Biochemistry and molecular biology of the human CYP2C subfamily

1 reference

12 December 2020

Haloperidol concentrations elevated in Chinese patients

1 reference

12 December 2020

Ethnic differences in drug disposition and responsiveness

1 reference

12 December 2020

Effect of steroids on the cytochrome P4502D6-catalysed metabolism of metoprolol

1 reference

12 December 2020

Reproducibility over Time of Mephenytoin and Debrisoquine Hydroxylation Phenotypes

1 reference

12 December 2020

Interethnic variation of drug metabolism

1 reference

12 December 2020

Smoking and drug metabolism

1 reference

12 December 2020

Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population

1 reference

12 December 2020

Debrisoquine hydroxylation polymorphism and personality

1 reference

12 December 2020

Comparison of the prevalence of the poor metabolizer phenotype for CYP2D6 between 203 Hmong subjects and 280 white subjects residing in Minnesota*

1 reference

12 December 2020

Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in man

1 reference

12 December 2020

Inhibitory effects of neuroleptics on debrisoquine oxidation in man

1 reference

12 December 2020

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1 reference

12 December 2020

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

12 December 2020

Genetically variable metabolism of antidepressants and neuroleptic drugs in man.

1 reference

12 December 2020

Haloperidol disposition is dependent on the debrisoquine hydroxylation phenotype: increased plasma levels of the reduced metabolite in poor metabolizers

1 reference

12 December 2020

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism

1 reference

12 December 2020

Haloperidol and reduced haloperidol plasma levels in Chinese vs. non-Chinese psychiatric patients

1 reference

12 December 2020

DEBRISOQUINE HYDROXYLATION PHENOTYPES IN HEALTHY VOLUNTEERS

1 reference

12 December 2020

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

1 reference

12 December 2020

Genetic and environmental factors affecting drug disposition in man

1 reference

12 December 2020

Haloperidol disposition is dependent on debrisoquine hydroxylation phenotype

1 reference

12 December 2020

Pharmacokinetics of haloperidol

1 reference

12 December 2020

Debrisoquin oxidation polymorphism in a Spanish population

1 reference

12 December 2020

Frequency of S-mephenytoin hydroxylation deficiency in 373 spanish subjects compared to other Caucasian populations

1 reference

12 December 2020

Clinical significance of the sparteine/debrisoquine oxidation polymorphism

1 reference

12 December 2020

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

1 reference

12 December 2020

Haloperidol and prolactin concentrations in Asians and Caucasians

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03190261

1 reference

Dimensions Publication ID

27 September 2017

1042285799

0 references

1 reference